×
About 7,577 results

ALLMedicine™ Diabetic Ketoacidosis Center

Research & Reviews  2,729 results

Disparities in Utilization and Outcomes with Continuous Subcutaneous Insulin Infusion i...
https://doi.org/10.1016/j.eprac.2021.05.001
Endocrine Practice : Official Journal of the American Col... McKee AM, Al-Hammadi N et. al.

May 15th, 2021 - To evaluate what factors determine utilization patterns and outcomes of continuous subcutaneous insulin infusion (CSII) in young adults with type 1 diabetes (T1D). Utilizing the Optum® de-identified Electronic Health Record (EHR) dataset between 2...

Delayed referral is common even when new-onset diabetes is suspected in children. A Swe...
https://doi.org/10.1111/pedi.13229
Pediatric Diabetes; Wersäll JH, Adolfsson P et. al.

May 12th, 2021 - Delayed treatment for new-onset diabetes type 1 (T1D) can lead to diabetic ketoacidosis (DKA) with potentially devastating consequences. This prospective observational study aimed to characterize pediatric patients with DKA at hospital admission, ...

Comparing patient characteristics and outcomes in type 1 versus type 2 diabetes with di...
https://doi.org/10.1136/jim-2021-001901
Journal of Investigative Medicine : the Official Publicat... Shaka H, Wani F et. al.

May 11th, 2021 - Diabetic ketoacidosis (DKA) is a known complication of patients with type 1 diabetes mellitus (T1DM), but less common in type 2 diabetes mellitus (T2DM). The aim of this study was to compare the outcomes of patients admitted to the hospital with D...

Managing Diabetic Ketoacidosis in Children.
https://doi.org/10.1016/j.annemergmed.2021.02.028
Annals of Emergency Medicine; Tzimenatos L, Nigrovic LE

May 10th, 2021 - Managing Diabetic Ketoacidosis in Children.|2021|Tzimenatos L,Nigrovic LE,|

Diabetes: Device Therapy.
https://www.ncbi.nlm.nih.gov/pubmed/33970589
FP Essentials; Pasarica M

May 10th, 2021 - Insulin pumps, continuous glucose monitors (CGMs), and hybrid closed-loop insulin pumps with CGMs are available for the management of type 1 diabetes in patients of all ages and type 2 diabetes in patients treated with multiple daily injections of...

see more →

Guidelines  17 results

ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID...
https://doi.org/10.1111/pedi.13118
Pediatric Diabetes REFERENCES; Priyambada L, Wolfsdorf JI et. al.

Sep 16th, 2020 - The International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guideline 2018 for management of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state provide comprehensive guidance for management of DKA ...

Diabetic ketoacidosis: A consensus statement of the Italian Association of Medical Diab...
https://doi.org/10.1016/j.numecd.2020.06.006
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Lapolla A, Amaro F et. al.

Aug 10th, 2020 - Diabetic ketoacidosis (DKA) is a serious medical emergency once considered typical of type 1 diabetes (T1DM), but now reported to occur in type 2 and GDM patients as well. DKA can cause severe complications and even prove fatal. The aim of our stu...

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 27th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors
http://care.diabetesjournals.org/content/42/6/1147
Diabetes Care; Danne,T.,et al

May 31st, 2019 - Sodium–glucose cotransporter (SGLT) inhibitors are new oral antidiabetes medications shown to effectively reduce glycated hemoglobin (A1C) and glycemic variability, blood pressure, and body weight without intrinsic properties to cause hypoglycemia...

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycem...
https://cdn.ymaws.com/www.ispad.org/resource/resmgr/consensus_guidelines_2018_/11.diabetic_ketoacidosis_and.pdf

Apr 10th, 2018 - The biochemical criteria for the diagnosis of diabetic ketoacidosis (DKA) are: Hyperglycemia (blood glucose >11 mmol/L [≈200 mg/dL]) Venous pH <7. 3 or serum bicarbonate <15 mmol/L Ketonemia (blood ß-hydroxybuyrate ≥3 mmol/L) or moderate or large k.

see more →

Drugs  695 results see all →

Clinicaltrials.gov  3,733 results

Glimepiride - glimepiride tablet-Solco Healthcare U.S., LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86acdd9e-8637-43e4-8bf7-b3a123b871b8

Aug 12th, 2021 - Glimepiride tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14.1) ]. Limitations of Use Glimepiride tablets USP should not be used for the trea...

Disparities in Utilization and Outcomes with Continuous Subcutaneous Insulin Infusion i...
https://doi.org/10.1016/j.eprac.2021.05.001
Endocrine Practice : Official Journal of the American Col... McKee AM, Al-Hammadi N et. al.

May 15th, 2021 - To evaluate what factors determine utilization patterns and outcomes of continuous subcutaneous insulin infusion (CSII) in young adults with type 1 diabetes (T1D). Utilizing the Optum® de-identified Electronic Health Record (EHR) dataset between 2...

Delayed referral is common even when new-onset diabetes is suspected in children. A Swe...
https://doi.org/10.1111/pedi.13229
Pediatric Diabetes; Wersäll JH, Adolfsson P et. al.

May 12th, 2021 - Delayed treatment for new-onset diabetes type 1 (T1D) can lead to diabetic ketoacidosis (DKA) with potentially devastating consequences. This prospective observational study aimed to characterize pediatric patients with DKA at hospital admission, ...

Comparing patient characteristics and outcomes in type 1 versus type 2 diabetes with di...
https://doi.org/10.1136/jim-2021-001901
Journal of Investigative Medicine : the Official Publicat... Shaka H, Wani F et. al.

May 11th, 2021 - Diabetic ketoacidosis (DKA) is a known complication of patients with type 1 diabetes mellitus (T1DM), but less common in type 2 diabetes mellitus (T2DM). The aim of this study was to compare the outcomes of patients admitted to the hospital with D...

Managing Diabetic Ketoacidosis in Children.
https://doi.org/10.1016/j.annemergmed.2021.02.028
Annals of Emergency Medicine; Tzimenatos L, Nigrovic LE

May 10th, 2021 - Managing Diabetic Ketoacidosis in Children.|2021|Tzimenatos L,Nigrovic LE,|

see more →

News  399 results

Most Kids With Type 1 Diabetes and COVID-19 in US Fared Well
https://www.medscape.com/viewarticle/950277

Apr 29th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The majority of children with type 1 diabetes who tested positive for SARS-CoV-2 were cared for at home and did well, according to the first repor...

1 in 5 Hospitalized With Diabetic Ketoacidosis Is Readmitted
https://www.medscape.com/viewarticle/947922

Mar 22nd, 2021 - About one in five people with type 1 diabetes in the United States hospitalized with diabetic ketoacidosis (DKA) is readmitted within 30 days, new research shows. The results from the National Readmission Database also show that deaths are higher ...

Pumps and Patches: Technology Benefits Youth With Type 1 Diabetes
https://www.medscape.com/viewarticle/947742

Mar 18th, 2021 - An increase in the use of insulin pumps and continuous glucose monitoring (CGM) around the world is benefiting children with type 1 diabetes, new research finds. An analysis of data for more than 25,000 participants aged 18 years or younger with t...

COVID-19 Complicates Diabetic Ketoacidosis in Hospital
https://www.medscape.com/viewarticle/947200

Mar 9th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The clinical course and prognosis of individuals hospitalized with diabetic ketoacidosis (DKA) are considerably worse among those who have COVID-1...

Further Warning on SGLT2 Inhibitor Use and DKA Risk in COVID-19
https://www.medscape.com/viewarticle/944267

Jan 17th, 2021 - Use of sodium-glucose cotransporter 2 (SGLT2) inhibitors during acute COVID-19 illness raises the risk for euglycemic diabetic ketoacidosis (euDKA), a new case series suggests. Five patients with type 2 diabetes who were taking SGLT2 inhibitors pr...

see more →

Patient Education  4 results see all →